Clinical Trial Update: Stem Cell Transplantation to Treat Systemic Mastocytosis [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating stem cell transplantation as a treatment for systemic mastocytosis. The study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Mastocytosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Mastocytosis | Phase 2 | Status: COMPLETED